![Cabinet nod to ₹9,589 cr FDI in Suven Pharma; stock surges 5%](https://images.assettype.com/fortuneindia%2F2022-12%2Fd8f0326a-d911-4024-8228-5f6e4307e55a%2FMarket_3.jpg?w=300&q=95)
Cabinet nod to ₹9,589 cr FDI in Suven Pharma; stock surges 5%
Cabinet approves FDI worth up to ₹9,589 cr in Suven by Cyprus-based Berhyanda for a 76.1% stake
Cabinet approves FDI worth up to ₹9,589 cr in Suven by Cyprus-based Berhyanda for a 76.1% stake
Advent plans to merge its portfolio company Cohance Lifesciences with Suven to build an end-to-end CDMO and merchant API.